A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany.

Expert review of pharmacoeconomics & outcomes research

Volumn 12, Issue 5, 2012, Pages 631-643

  Jiang, Yiling ^a   Gauthier, Aline ^b   Annemans, Lieven ^b   van der Linden, Mark ^b   Nicolas Spony, Laurence ^b   Bresse, Xavier ^b  

^a Amaris   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

13 VALENT PNEUMOCOCCAL VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE; 23 VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE; 23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BUDGET; COHORT ANALYSIS; COMPARATIVE STUDY; ECONOMICS; GERMANY; HUMAN; INCIDENCE; MIDDLE AGED; PNEUMOCOCCAL INFECTION; PROBABILITY; PUBLIC HEALTH; TIME; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; BUDGETS; COHORT STUDIES; GERMANY; HUMANS; INCIDENCE; MARKOV CHAINS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PUBLIC HEALTH; TIME FACTORS; YOUNG ADULT;

EID: 84877135322     PISSN: None     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.12.55     Document Type: Article

References (0)